1. Home
  2. JAZZ vs MTH Comparison

JAZZ vs MTH Comparison

Compare JAZZ & MTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAZZ
  • MTH
  • Stock Information
  • Founded
  • JAZZ 2003
  • MTH 1985
  • Country
  • JAZZ Ireland
  • MTH United States
  • Employees
  • JAZZ N/A
  • MTH N/A
  • Industry
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • MTH Homebuilding
  • Sector
  • JAZZ Health Care
  • MTH Consumer Discretionary
  • Exchange
  • JAZZ Nasdaq
  • MTH Nasdaq
  • Market Cap
  • JAZZ 6.5B
  • MTH 6.9B
  • IPO Year
  • JAZZ 2007
  • MTH 1988
  • Fundamental
  • Price
  • JAZZ $122.49
  • MTH $163.68
  • Analyst Decision
  • JAZZ Buy
  • MTH Hold
  • Analyst Count
  • JAZZ 14
  • MTH 9
  • Target Price
  • JAZZ $173.93
  • MTH $193.71
  • AVG Volume (30 Days)
  • JAZZ 539.6K
  • MTH 345.3K
  • Earning Date
  • JAZZ 11-06-2024
  • MTH 01-29-2025
  • Dividend Yield
  • JAZZ N/A
  • MTH 1.83%
  • EPS Growth
  • JAZZ 458.10
  • MTH 2.15
  • EPS
  • JAZZ 7.04
  • MTH 22.10
  • Revenue
  • JAZZ $3,992,712,000.00
  • MTH $6,433,727,000.00
  • Revenue This Year
  • JAZZ $7.51
  • MTH $4.44
  • Revenue Next Year
  • JAZZ $6.82
  • MTH $8.38
  • P/E Ratio
  • JAZZ $17.38
  • MTH $7.41
  • Revenue Growth
  • JAZZ 5.23
  • MTH N/A
  • 52 Week Low
  • JAZZ $99.06
  • MTH $147.77
  • 52 Week High
  • JAZZ $134.17
  • MTH $213.98
  • Technical
  • Relative Strength Index (RSI)
  • JAZZ 53.16
  • MTH 30.60
  • Support Level
  • JAZZ $121.22
  • MTH $166.45
  • Resistance Level
  • JAZZ $126.23
  • MTH $186.51
  • Average True Range (ATR)
  • JAZZ 2.83
  • MTH 5.51
  • MACD
  • JAZZ -0.23
  • MTH -2.20
  • Stochastic Oscillator
  • JAZZ 50.43
  • MTH 1.58

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About MTH Meritage Homes Corporation

Meritage Homes Corp is engaged as a designer and builder of single-family attached and detached homes. It has operations in three regions: West, Central, and East, which are comprised of ten states: Arizona, California, Colorado, Texas, Florida, Georgia, North Carolina, South Carolina, Tennessee, and Utah. The company operates with two principal business segments; homebuilding and financial services. The homebuilding segments are engaged in the business of acquiring and developing land, constructing homes, marketing and selling those homes and providing warranty and customer services and the financial services segment offer title and escrow, mortgage, and insurance services. The company generates key revenue from the homebuilding segment.

Share on Social Networks: